Summary
The product PRIMOS 100 mg/ml, manufactured by Driada Medical, underwent independent laboratory testing to confirm its composition and dosage accuracy. The analysis, conducted by Janoshik Analytical, identified the active ingredient as methenolone enanthate, with a measured concentration of 96.33 mg/ml. This result is 3.67% below the labeled claim of 100 mg/ml, indicating a minor variance from the stated specification.
Testing was initiated on 1 September 2022, the sample was received on 8 September 2022, and the analysis concluded on 13 September 2022. The product was submitted and funded by Driada Medical, emphasizing the importance of critically assessing the results.
Detailed Report
Product Overview
- Manufacturer: Driada Medical
- Product Name: PRIMOS 100 mg/ml
- Active Ingredient: Methenolone Enanthate
- Batch Number: 191198
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #23729
- Testing Ordered: 1 September 2022
- Sample Received: 8 September 2022
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Driada Medical
- Analysis Paid For By: Driada Medical
Testing Results
- Specification: 100 mg/ml (as stated on the label)
- Measured Concentration: 96.33 mg/ml
- Accuracy: 96.33% (3.67% below the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/23729_4PINWY9JXCQP
- Originally Published: https://thinksteroids.com/community/posts/3014846/
Evaluation of Manufacturer-Funded Testing
Given that the testing was submitted and funded by Driada Medical, it is essential to consider the possibility of conflicts of interest. Nonetheless, the report from Janoshik Analytical provides transparency and reliability, showing only a minor deviation from the labeled claim.
Conclusion
The analysis of PRIMOS 100 mg/ml confirms the presence of methenolone enanthate at a concentration close to the label claim, with a minor deviation of 3.67%. This result highlights the product’s consistency and reliability, aligning with harm reduction objectives.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-funded testing may involve inherent biases; however, it can still provide valuable data when critically assessed alongside independent results. Readers are encouraged to interpret this information responsibly.
